Line 12: | Line 12: | ||
<svg version="1.1" id="Ebene_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" | <svg version="1.1" id="Ebene_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" | ||
− | width="820px" height="2648 | + | width="820px" height="2648.4px" viewBox="158.498 284.203 612.382 1977.85" |
enable-background="new 158.498 284.203 612.382 1977.85" xml:space="preserve"> | enable-background="new 158.498 284.203 612.382 1977.85" xml:space="preserve"> | ||
<line fill="#196B94" stroke="#196B94" stroke-miterlimit="10" x1="364.311" y1="1625.391" x2="598.166" y2="1625.391"/> | <line fill="#196B94" stroke="#196B94" stroke-miterlimit="10" x1="364.311" y1="1625.391" x2="598.166" y2="1625.391"/> |
Revision as of 17:02, 17 October 2018
Dependence on petrochemicals derived from oil and gas poses a major problem in the plastics industry and polymer production. Establishing biological precursors for high quality polymers is a hurdle we want to tackle.
We were driven by the idea of constructing an eco-friendly polymer usable for human medical applications. During our research, we stumbled upon PLGA (Poly(lactic-co-glycolic-acid)) and PLGC (Poly(lactide-co-glycolide-co-caprolactone)). In our case, they consist of renewable resources (glycolic acid, ε-caprolactone and lactic acid) and degrade after a controllable period of time into non-toxic compounds, which pose no further danger to the environment, as well as the human body.
For more background information visit our subpage.